# Amado Viera, M.D. – FDA 483, Jul 2, 2026

Source: https://www.keypedia.com/records/483/amado-viera-md/56142d65-9a53-48cb-b857-a5aaf833b2ee

> FDA 483 for Amado Viera, M.D. on July 02, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Amado Viera, M.D.
- Inspection Date: 2026-07-02
- Product Type: drugs
- Office Name: Florida District Office
- Summary: An FDA inspection of Unique Clinical Trials, LLC in Doral, FL, revealed significant deficiencies in the conduct of clinical trials. The firm failed to adhere to investigational plans, enrolling ineligible subjects and not reporting adverse events as required. Additionally, inadequate and inaccurate case histories were maintained, with restricted medications not being documented.

## Related Officers

- [Chantae D. Mitchell](https://www.keypedia.com/people/chantae-d-mitchell/0da68244-86f3-4119-b965-0b2dceb1c523)

Company: https://www.keypedia.com/companies/amado-viera-md/df9e8b4f-52cd-4376-be96-8295c106e0ba

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9